Filing Details
- Accession Number:
- 0000899243-22-012980
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-31 19:19:00
- Reporting Period:
- 2022-03-29
- Accepted Time:
- 2022-03-31 19:19:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415684 | Musclepharm Corp | MSLP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1008190 | Mark Blundell | C/O White Winston Select Asset Funds, Ll 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1559652 | P Robert Mahoney | C/O White Winston Select Asset Funds, Ll 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1647702 | M. Todd Enright | C/O White Winston Select Asset Funds, Ll 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1647837 | Donald Feagan | C/O White Winston Select Asset Funds, Ll 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1647840 | White Winston Select Asset Funds, Llc | 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No | |
1738154 | White Winston Select Asset Fund Series Fund Mp-18, Llc | 265 Franklin St., Suite 1702 Boston MA 02110 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-03-29 | 626,826 | $0.00 | 3,021,529 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On March 29, 2022 (the "Transaction Date"), the Reporting Persons transferred 626,826 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), in an off-market transaction (the "Transaction").
- For purposes of the Transaction, the value of the transferred shares of Common Stock was deemed to be $0.39 per share, the last reported sale price of the Issuer's Common Stock on the Transaction Date.